Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-08-30 to 2024-04-03
Current total value of award: $0
Description: MONOCLONAL ANTIBODY PRODUCTION OF PVS230